<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijerph-17-05904-t004" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijerph-17-05904-t004_Table 4</object-id>
 <label>Table 4</label>
 <caption>
  <p>Antivirals included in the treatment guidelines issued by NHC of China for COVID-19, version 6 [
   <xref rid="B107-ijerph-17-05904" ref-type="bibr">107</xref>,
   <xref rid="B109-ijerph-17-05904" ref-type="bibr">109</xref>]. NHC, National Health Commission; t.i.d, three times a day; b.i.d, two times a day.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug Regimen</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dosage</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Route of Administration</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Length of Therapy</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Ribavirin</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">500 mg, t.i.d, combination therapy with lopinavir/ritonavir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">IV infusion</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">≤10 days</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Chloroquine phosphate</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">500 mg one time, b.i.d</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Orally</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">≤10 days</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Arbidol</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">200 mg, one time, t.i.d</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Orally</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">≤10 days</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Lopinavir/ritonavir</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">200 mg/50 mg, dosage form: capsule, two capsules one time, b.i.d</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Orally</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">≤10 days</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-α</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 million U dose one time, b.i.d</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vapor inhalation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">≤10 days</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
